Corcept Therapeutics Inc (NASDAQ: CORT) is 38.88% higher on its value in year-to-date trading and has touched a low of $28.04 and a high of $117.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CORT stock was last observed hovering at around $69.51 in the last trading session, with the day’s gains setting it 0.47%.
Currently trading at $69.98, the stock is -5.21% and -3.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing 0.68% at the moment leaves the stock 22.35% off its SMA200. CORT registered 131.95% gain for a year compared to 6-month gain of 21.32%. The firm has a 50-day simple moving average (SMA 50) of $72.2142 and a 200-day simple moving average (SMA200) of $57.19515.
The stock witnessed a -5.36% loss in the last 1 month and extending the period to 3 months gives it a 26.11%, and is -9.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.88% over the week and 2.60% over the month.
Corcept Therapeutics Inc (CORT) has around 500 employees, a market worth around $7.42B and $685.45M in sales. Current P/E ratio is 60.74 and Fwd P/E is 26.31. Profit margin for the company is 19.33%. Distance from 52-week low is 149.57% and -40.36% from its 52-week high. The company has generated returns on investments over the last 12 months (19.23%).
with sales reaching $199.39M over the same period.The EPS is expected to grow by 11.99% this year, but quarterly earnings will post 33.18% year-over-year. Quarterly sales are estimated to grow 21.73% in year-over-year returns.
554.0 institutions hold shares in Corcept Therapeutics Inc (CORT), with institutional investors hold 90.14% of the company’s shares. The shares outstanding are 105.98M, and float is at 93.77M with Short Float at 13.31%. Institutions hold 79.79% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 16.54 million shares valued at $$537.36 million. The investor’s holdings represent 16.0391 of the CORT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 9.55 million shares valued at $$310.4 million to account for 9.2648 of the shares outstanding. The other top investors are INGALLS & SNYDER LLC which holds 8.24 million shares representing 7.989 and valued at over $$267.66 million, while RENAISSANCE TECHNOLOGIES LLC holds 6.7036 of the shares totaling 6.91 million with a market value of $$224.59 million.
Corcept Therapeutics Inc (CORT) Insider Activity
The most recent transaction is an insider sale by BELANOFF JOSEPH K, the company’s Chief Executive Officer. SEC filings show that BELANOFF JOSEPH K sold 40,000 shares of the company’s common stock on Jun 02 ’25 at a price of $82.86 per share for a total of $3.31 million. Following the sale, the insider now owns 2.9 million shares.
Corcept Therapeutics Inc disclosed in a document filed with the SEC on Jun 02 ’25 that Lyon Joseph Douglas sold a total of 5,000 shares of the company’s common stock. The trade occurred on Jun 02 ’25 and was made at $78.04 per share for $0.39 million. Following the transaction, the insider now directly holds 9009.0 shares of the CORT stock.
Still, SEC filings show that on Jun 02 ’25, Maduck Sean disposed off 20,000 shares at an average price of $79.08 for $1.58 million. The insider now directly holds 17,705 shares of Corcept Therapeutics Inc (CORT).
